These MEKs, in turn, phosphorylate/activate MAPKs (e.g., JNK and p38 MAPK) and ERKs, which activate various oncogenic transcription factors (e.g., c-Myc, c-Jun, and c-Fos) involved in tumor progression and survival[17,18]. This evidence concerns the gene MAPK8 and neoplasm.